The membership of the ACS may elect additional Council members to advise the executive council and provide adequate representation of the membership, for example in terms of cytometry field (research, clinical, industrial) or geographical area (Australia, New Zealand). Additional Council members shall serve until the next Annual General Meeting.
Current Advisory Council:
Peter Gambell and Simon Monard: Ex Officio Conference Co-Conveners
The 42nd Annual Scientific Meeting of the ACS will be co-chaired by Peter Gambell and Simon Monard.
Peter Gambell is the Principal Scientist & Deputy Operations Director at Peter MacCallum Cancer Centre Pathology Department. He graduated from RMIT (BAppSc-MLS) in 1992 and worked at The Austin Hospital for almost 10 years. After spending the first few years in Haematology & Blood-bank labs at The Austin, he moved across to the Immunology laboratory where he developed his passion for Diagnostic Clinical Flow Cytometry. He moved to Dorevitch Pathology in 2001 where he setup a diagnostic Oncology Flow Cytometry laboratory. He has held his current position at Peter Mac since 2002. Peter completed his Masters in Health Services Management at Monash University in 2005. He is a member of a number of professional societies including the ACS, AIMS (currently Chair AIMS-Vic branch), ISLH, ISCT & HSANZ. He is currently a Project Panel member of the International Committee for Standardization in Haematology (ICSH), working on the development of a new “gold”standard method (flow-based) for WBC differential counting.
Simon Monard is the head of flow cytometry at the Walter and Eliza Hall Institute. Simon graduated with a BSc Hons from University College London in Zoology and completed a Masters in Immunology at Kings College London shortly thereafter. He started working in a flow cytometry lab within Imperial Cancer Research Fund (now Cancer Research UK). For the last 30 years Simon has been managing cytometry labs in the UK, Portugal, the United States and now Australia. His interests include optimizing and improving instrument performance, high dimensional cytometry and single cell biology.
Dr Anna Brooks: Research Adviser
Dr Anna Brooks holds a BCA (management) and a PhD in Immunology and is a Research Fellow with the Maurice Wilkins Centre at the University of Auckland, New Zealand. She has been using flow cytometry for most of her research years, but has also been managing and enhancing the capabilities of the flow cytometry facility housed in Professor Rod Dunbar’s immunology lab (School of Biological Sciences) for the last 8 or so years. Anna recently launched and now directs this platform, Auckland Cytometry, as a shared resource facility for the Faculty of Science. In addition, Anna is currently facilitating a collaboration with Auckland Genomics to establish a pipeline for single cell transcriptomics (scRNAseq), the first of its kind in New Zealand.
Anna is experienced in multicolour panel development, especially for the characterisation of complex cellular populations in digested human tissues. Anna’s current research interest lies in dissecting the heterogeneity of mesenchymal cells in human adipose tissue using both flow cytometric and proteogenomic techniques (CITEseq/scRNAseq). In addition, Anna is an associate investigator on an on-going international collaboration with the role of developing multicolour panels (20+ colours) to monitor immune responses for clinical trials.
Anna is an active member of the international flow cytometry community and regularly attends and presents at both cytometry and research interest conferences. Anna is passionate about teaching flow cytometric best practices and has presented and facilitated a number of workshops, including at the international CYTO conferences. She has also sat on a number of conference organising and national grant reviewing committees. As well as ACS, Anna is also a member of the Australian Society for Immunology, the Australasian Society for Stem Cell Research, the International Society for Advancement of Cytometry and the International Society for Stem Cell Research
Dr Sheree Bailey: Clinical Adviser
Dr Sheree Bailey is the Head of Unit in the Flow Cytometry Facility, SA Pathology at Flinders Medical Centre and Senior Lecturer, Flinders University. The SA Pathology diagnostic unit specialises in leukaemia and lymphoma and minimal residual disease analysis. Highlights include the implementation of standardised flow cytometry assays to assess the level of minimal residual disease in chronic lymphocytic leukaemia and more recently, in myeloma patients. Sheree is a member of the RCPA Immunophenotyping Advisory Committee.
Sheree also manages the Flinders University Cytometry Facility at Flinders Medical Centre and she has completed a Graduate Diploma of Management. She completed her PhD at Flinders University (part time) in 2017 demonstrating skills in multicolour panel design and data analysis, apoptosis, phosphoprotein and calcium signaling and ImageStream X analysis.
Sheree is a past Treasurer of the ACS (2004) and was Clinical Program Coordinator for the 2018 Annual Scientific meeting in Adelaide. She is also a member of the ACS Clinical Guidelines Taskforce. Sheree is keen to continue the promotion of education and training by the ACS and to develop collaborations between ACS members in clinical cytometry.
Dr Maggie Wang: SRL Adviser
Dr Xin Maggie Wang obtained her Masters in Science in 2001 and a PhD in 2007 at the Department of Medicine, the University of Sydney, Australia. She took the senior flow cytometry scientist position at the Western Sydney Area Health in 2008 and became manager of the Westmead Research Hub flow cytometry core facility in 2011. In 2016, she was promoted as Scientific Platforms Manager responsible for seven scientific platforms including flow cytometry at the Westmead Institute for Medical Research, Westmead Research Hub, the University of Sydney. She has been a member of ISAC and ACS since 2008 and became a member of ACS Council in 2017 to represent SRL members. She has participated in ISAC Live Education Task Force activities since 2017 and presented at a number of flow cytometry workshops. For last ten years she has been heavily involved in providing advise and assistance with the development of flow cytometry applications, designing a new flow cytometry core facility, establishing business models, investigating new lab management systems, setting up the biosafety procedures as well as collaborating with several researcher groups.
Kylie Price: International Engagement Adviser
As Head of Research Technology at the Malaghan Institute of Medical Research (MIMR) Kylie has worked in cytometry for 13 years and has been responsible for driving the creation of a state-of-the-art cytometry facility at New Zealand’s leading independent biomedical institute, which includes flow and spectral cytometry, microscopy and immunohistochemistry. Managing a shared resource laboratory with three staff, she provides more than 70 MIMR research scientists with expertise and access to cytometry instrumentation to advance their research goals.
Kylie has been credited with pioneering the use of multicolour flow cytometry and spectral cytometry within New Zealand and enjoys using cytometry for as wide a range of research applications as possible. She has analysed and sorted: side-population cells from primary human brain tissue, bacteria from Antarctic sea-ice, bovine sperm and algal spores, to name a few. She is the first New Zealander elected to the International Society for Advancement of Cytometry (ISAC) council (2018-2024), a member of ISAC’s Proliferation Content Author Group for CYTO University and the Live Education Task Force, she is a Past President of the Australasian Cytometry Society (2015-2016), she also played a crucial role instigating and facilitating CYTOAsia Singapore 2016 and is actively involved in planning CYTOAsia Shanghai 2019.
Through collaboration, she has developed innovative cytometry solutions to address researcher needs, including cell preparation, cell analysis, panel design, data interpretation and presentation. In 2012, Kylie arranged a “technology transfer sabbatical” in Spain, spending time in some of the most advanced flow cytometry facilities in Spain and Europe. The aim was both to gain a broader range of cytometry experience, as well as to train cytometry users in Spain from a wide range of scientific backgrounds, about the power, advancements and flexibility of flow cytometry. This experience also provided her with a vision and roadmap for how to grow the cytometry core facility at MIMR in the future.